128 reports of this reaction
1.2% of all BRIVARACETAM reports
#17 most reported adverse reaction
MEMORY IMPAIRMENT is the #17 most commonly reported adverse reaction for BRIVARACETAM, manufactured by Apotex Corp.. There are 128 FDA adverse event reports linking BRIVARACETAM to MEMORY IMPAIRMENT. This represents approximately 1.2% of all 10,449 adverse event reports for this drug.
Patients taking BRIVARACETAM who experience memory impairment should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MEMORY IMPAIRMENT is a less commonly reported adverse event for BRIVARACETAM, but still significant enough to appear in the safety profile.
In addition to memory impairment, the following adverse reactions have been reported for BRIVARACETAM:
The following drugs have also been linked to memory impairment in FDA adverse event reports:
MEMORY IMPAIRMENT has been reported as an adverse event in 128 FDA reports for BRIVARACETAM. This does not prove causation, but indicates an association observed in post-market surveillance data.
MEMORY IMPAIRMENT accounts for approximately 1.2% of all adverse event reports for BRIVARACETAM, making it a notable side effect.
If you experience memory impairment while taking BRIVARACETAM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.